Dudediligence.

Metagenomi Therapeutics, Inc

MGXNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Sep 228-KRegulation FD disclosure7.019.01
  2. Sep 1013GPassive stake of 5% or more (13G), filed by Brian C. Thomas
  3. Aug 1010-QQuarterly report
  4. Aug 108-KResults of operations2.029.01
  5. Jun 98-KOfficer or director change and shareholder vote5.025.07
  6. May 1110-QQuarterly report
  7. May 118-KResults of operations and Regulation FD disclosure2.027.019.01
  8. Mar 510-KAnnual report
  9. Mar 58-KResults of operations2.029.01
  10. Jan 128-KBylaws or fiscal year changed and Regulation FD disclosure5.037.019.01
  11. Nov 12, 202510-QQuarterly report
  12. Nov 12, 20258-KResults of operations and Regulation FD disclosure2.027.019.01
  13. Oct 1, 20258-KMaterial agreement and end of a material agreement1.011.02
  14. Aug 12, 202510-QQuarterly report
  15. Aug 12, 20258-KResults of operations and Regulation FD disclosure2.027.019.01
  16. Jun 10, 20258-KShareholder vote5.07
  17. May 14, 20258-KOther events8.01
  18. May 13, 202510-QQuarterly report
  19. May 13, 20258-KResults of operations and Regulation FD disclosure2.027.019.01
  20. Mar 17, 20258-KMaterial agreement1.019.01
  21. Mar 17, 2025S-3Shelf registration
  22. Mar 17, 20258-KResults of operations and Regulation FD disclosure2.027.019.01
  23. Mar 17, 202510-KAnnual report
  24. Jan 16, 20258-KOfficer or director change and Regulation FD disclosure5.027.019.01
  25. Dec 10, 20248-KOther events8.019.01
  26. Nov 13, 20248-KResults of operations2.029.01
  27. Nov 13, 202410-QQuarterly report